A randomized and open-label phase I clinical study registered with ClinicalTrials.gov #NCT @ , aims to evaluate the safety , reactogenicity and immunogenicity of a formalin-inactivated EV@ vaccine candidate ( EV@vac ) at @ - and @-g doses .